[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569160":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":52,"collaborators":24,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":56,"sex":62,"minAge":63,"maxAge":24,"enrollmentInfo":64,"targetDuration":24,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":37,"whyStopped":24,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"University Hospital, Toulouse","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"WATER","EXPERIMENTAL","ingestion of 1.5L of water 30min prior MRE acquisition",[13],"Other: water preparation",{"label":15,"type":16,"description":17,"interventionNames":18},"PEG","ACTIVE_COMPARATOR","ingestion of 1.5L of water diluted PEG 45 min prior MRE acquisition (standard protocol)",[19],"Other: polyethylene glycol preparation",[21,25],{"type":6,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"water preparation",[9],null,{"type":6,"name":26,"description":17,"armGroupLabels":27,"otherNames":24},"polyethylene glycol preparation",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},"Guillaume Dr LE COSQUER, MD","CONTACT","+33 (0)5 61 32 20 45","lecosquer.g@chu-toulouse.fr",[35],{"facility":36,"status":37,"city":38,"state":24,"zip":24,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"CHU Toulouse","RECRUITING","Toulouse","France","FR",{"type":42,"coordinates":43},"Point",[44,45],1.44367,43.60426,{"lat":45,"lon":44},[48],{"name":49,"role":31,"phone":50,"phoneExt":24,"email":51},"Cindy CANIVET","(+33 5 61 3)2 20 48","canivet.c@chu-toulouse.fr",{"type":53,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100569160","water-preparation-in-crohns-diseases-imagery-100569160",false,"NCT06690632","WAter Preparation in Crohn's Disease's Imagery","WAter Preparation for Magnetic Resonance Enterography in Crohn's Disease","WAM","Inclusion criteria:\n\n* Diagnosis of Crohn's Disease,\n* need for MRE (determined by patient's gastroenterologist)\n\nExclusion criteria:\n\n* \\\u003C 18 years old,\n* inability to obtain an informed consent,\n* patient under guardianship or curatorship, allergy to PEG,\n* contraindication to MRE (pregnancy, pace maker, claustrophobia in particular), - contraindication to phloroglucinol administration (phenylcetonuria),\n* contraindication to gadolinium administration (kidney failure with glomerular filtration rate \\\u003C 30\u002FmL\u002F1.73m², pregnancy, allergy).","ALL","18 Years",{"count":65,"type":66},194,"ESTIMATED","INTERVENTIONAL",[69],"NA","The goal of this clinical trial is to compare distension quality and patient experience of water and polyethylene glycol preparation as oral contrast media in Magnetic Resonance Enterography (MRE) in patients with Crohn's disease.\n\nThus, the main question it aims to answer is:\n\nIs water sufficient to interpret MRE from patients with Crohn's disease?\n\nResearchers will compare the standard protocol (polyethylene glycol) with water as bowel distension agent to see if it is possible to obtain a satisfying global distension of small bowel.\n\nParticipants will undergo the same procedures as standard care adding questionnaires and replacing water as the bowel distension agent for the MRE for patient randomized into the experimental group.",[72],"Crohn Disease (CD)",[74,75,76,77,78],"Crohn","bowel distension","MRE","oral contrast media","tolerability","2026-05-07",{"date":81,"type":82},"2026-05-08","ACTUAL",{"date":84,"type":82},"2025-01-29",{"date":86,"type":66},"2028-12-01",{"name":5,"class":6},1]